Influenza virus type B

DB15966ApprovedVaccines

Influenza virus type B is a live attenuated virus indicated for vaccination against certain strains of influenza. An ingredient in a flu vaccine.

First approval
Canada, 2025
Brand names
  • FluMist

Resolves to

Compound
UNII1314JZ2X6W
Clinical / RWD
RxNorm1657134

What you can answer from here — as of April 02, 2025

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
2Marketed productsAcross 2 countries and 2 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Influenza virus type B, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In